Published Date: 26-May-2023
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Dermal Fillers Market size is expected to reach $10.3 billion by 2029, rising at a market growth of 8.1% CAGR during the forecast period.
The Non-biodegradable segment is showcasing a CAGR of 8.7% during (2023 - 2029). This is owing to the rising demand for aesthetic procedures and increased knowledge of skin care products. As a result, the market has seen tremendous expansion in recent years. Non-biodegradable dermal fillers are chemicals injected into the skin to plump up wrinkles and increase volume. Synthetic or artificial collagen is another name for non-biodegradable dermal filler. It may contain polymethyl methacrylate (PMMA), calcium hydroxylapatite, other substances, or a mixture.
The Hyaluronic Acid segment acquired maximum revenue share in the Global Dermal Fillers Market by Product in 2022 thereby, achieving a market value of $6.7 billion by 2029. This is because hyaluronic acid (HA) is the industry standard for dermal fillers. New product launches in this category are also helping to fuel the segment's expansion. Hyaluronic acid-based products' rising popularity is largely due to their relative safety and longevity. The segment's expansion is also anticipated to be fueled by important companies that provide hyaluronic acid products in high-growing countries.
The MedSpa segment has shown the growth rate of 7.7% during (2023 - 2029). This is due to the fact that a licensed medical expert, such as a doctor or nurse practitioner, who has received specific training in the administration of dermal fillers, works at a medical spa. Knowing that a licensed and skilled medical expert is carrying out their therapy may make patients feel more at ease. They are created to give patients a relaxing and comforting environment.
The Wrinkle Correction segment is leading the Global Dermal Fillers Market by Application in 2022 thereby, achieving a market value of $3.1 billion by 2029. This is because dermal fillers are made to provide a modest, natural-looking augmentation that does not look overdone when used to treat wrinkles. They are, therefore, a well-liked option among consumers. In addition, they offer a non-surgical alternative for treating wrinkles and other aging symptoms. Most dermal fillers offer benefits lasting between 6 and 18 months.
The North America market dominated the Global Dermal Fillers Market by Region in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $4.1 billion by 2029. The Europe market is exhibiting a CAGR of 7.6% during (2023 - 2029). Additionally, The Asia Pacific market would display a CAGR of 9.1% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/dermal-fillers-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Bioplus Co. Ltd, Bioxis pharmaceuticals, Suneva Medical, Inc., Galderma S.A., Allergan PLC (AbbVie, Inc.), Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.), Revance Therapeutics, Inc., Medytox Inc., Merz Pharma GmbH & Co. KGaA and Prollenium Medical Technologies Inc.
Unique Offerings from KBV Research
North America Dermal Fillers Market size & Opportunities 2023-2029
Europe Dermal Fillers Market & Growth Forecast 2023-2029
Asia Pacific Dermal Fillers Market Share & Industry Outlook to 2029
LAMEA Dermal Fillers Market Growth, Trends & Forecasts 2023-2029